2200 Participants Needed

WeCare for Suicidal Thoughts

(WeCare Trial)

MA
DW
JH
Overseen ByJacqueline Holloway, PhD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: New York University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you are actively receiving mental health treatment, you may not be eligible to participate.

What data supports the effectiveness of the WeCare treatment for suicidal thoughts?

The Collaborative Assessment and Management of Suicidality (CAMS), a similar approach to WeCare, has been shown to be more effective than usual care in reducing suicidal thoughts and attempts in soldiers. Additionally, using technology to monitor and engage at-risk individuals, as mentioned in the Zero Suicide model, shows promise in improving care for suicidal patients.12345

How is the WeCare treatment for suicidal thoughts different from other treatments?

The WeCare treatment is unique because it involves a comprehensive system of care that includes a coordinated suicide-prevention team and possibly peer support, which is different from traditional treatments that may not offer such integrated and supportive approaches.678910

What is the purpose of this trial?

The overall goal of this study is to respond to the urgent need for an effective suicide prevention strategy for Black youth by examining the effectiveness of a systems-level strategy to recognize and respond to suicide risk among Black adolescents who present to emergency departments (EDs). The proposed strategy, WeCare, combines combines three components: (1) universal screening using the Computerized Adaptive Screen for Suicidal Youth (CASSY), (2) a brief intervention designed for Black youth with elevated suicide risk in for ED settings, Connections for Safety (CFS), that combines safety planning and strategies to support linkage to outpatient mental health services, and (3) supportive text messages to youth and parent/caregivers for six weeks following the youth's ED visit. Study objectives are (1) to integrate input from multiple stakeholders to inform and facilitate WeCare implementation, and (2) to use a hybrid one effectiveness-implementation design to evaluate its effectiveness.

Research Team

MA

Michael A Lindsey, PhD

Principal Investigator

New York University

Eligibility Criteria

This trial is for Black adolescents aged 12-19 who are experiencing suicidal thoughts and visit emergency departments. Participants must have a phone with texting, speak English, and be accompanied by consenting parents or guardians if under 18. It aims to help them through screening, a brief intervention tailored for Black youth in ED settings, and follow-up supportive texts.

Inclusion Criteria

Having a cellular phone with text messaging capacity
I am between 12-19 years old and may include my parent or guardian.
I am a teenager who speaks and understands English.
See 3 more

Exclusion Criteria

Adolescent is medically unstable
Adolescent does not have access to cellular phone
I have severe cognitive impairment.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (in-person)

Intervention

Participants receive the WeCare intervention, which includes universal screening, ED-based intervention, and text message follow-up

6 weeks
1 visit (in-person), ongoing text message support

Follow-up

Participants are monitored for safety and effectiveness after the intervention, with survey assessments at 3 and 6 months

12 months
2 visits (in-person or virtual)

Treatment Details

Interventions

  • WeCare
Trial Overview WeCare strategy is being tested which includes: (1) CASSY - a tool for suicide risk screening; (2) Connections for Safety (CFS), an ED-based intervention; and (3) six weeks of supportive text messages to the youth and their caregivers after the ED visit.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: WeCareExperimental Treatment1 Intervention
WeCare system of care - universal screening, ED-based intervention, text message follow-up.
Group II: Usual ServicesActive Control1 Intervention
Usual care for youth presenting to the ED will be the control condition.

Find a Clinic Near You

Who Is Running the Clinical Trial?

New York University

Lead Sponsor

Trials
249
Recruited
229,000+

University of Michigan

Collaborator

Trials
1,891
Recruited
6,458,000+

Findings from Research

Emphasizing early intervention and ongoing low-intensity contact with individuals at risk of suicide can be more effective than solely focusing on those deemed 'highest risk', suggesting a shift in treatment strategy.
The use of advanced interactive computer programs can enhance screening and training for healthcare providers, improving access to mental health services and continuity of care for suicidal individuals.
Suicide prevention in a treatment setting.Litman, RE.[2022]
In a randomized controlled trial with 148 U.S. Army Soldiers, the Collaborative Assessment and Management of Suicidality (CAMS) was found to significantly reduce suicidal ideation (SI) compared to enhanced care as usual (E-CAU) by 3 months, with a strong effect size (Cohen's d = 0.93).
Both CAMS and E-CAU led to improvements in various behavioral health outcomes, but CAMS showed a notable advantage in reducing suicidal thoughts, highlighting its potential as an effective intervention for Soldiers with significant suicidal ideation.
A Randomized Controlled Trial of the Collaborative Assessment and Management of Suicidality versus Enhanced Care as Usual With Suicidal Soldiers.Jobes, DA., Comtois, KA., Gutierrez, PM., et al.[2019]
The study analyzed responses from 49 patients regarding helpful aspects of their treatment for suicidal risk, leading to the development of a reliable coding system to identify major themes in their experiences.
Insights gained from 52 patients on what they learned from their clinical care can inform future suicide-specific treatments, highlighting the importance of patient feedback in improving therapeutic approaches.
Successful Treatment of Suicidal Risk.Schembari, BC., Jobes, DA., Horgan, RJ.[2022]

References

Suicide prevention in a treatment setting. [2022]
A Randomized Controlled Trial of the Collaborative Assessment and Management of Suicidality versus Enhanced Care as Usual With Suicidal Soldiers. [2019]
Successful Treatment of Suicidal Risk. [2022]
[Continuity of care following suicide-related compulsory admission]. [2008]
The Need for Innovation in Health Care Systems to Improve Suicide Prevention. [2022]
Screening, triage, and referral of patients who report suicidal thought during a primary care visit. [2022]
Piloting a Peer Support Program for Patients Who Screen Positive for Intimate Partner Violence, Suicidal Ideation, and Depression. [2023]
Effect of Augmenting Standard Care for Military Personnel With Brief Caring Text Messages for Suicide Prevention: A Randomized Clinical Trial. [2022]
A stepped care approach to clinical suicide prevention. [2022]
Qualitative Study of Telehealth Delivery of Suicide-Specific Group Treatment "Project Life Force". [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security